OWD
PFE icon

Osborn Williams & Donohoe’s Pfizer PFE Stock Holding History

Osborn Williams & Donohoe’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$3.98M Sell
128,624
-9,367
-7% -$319K 0.52% 56
2019
Q4 		$5.13M Sell
137,991
-3,604
-3% -$128K 0.51% 57
2019
Q3 		$4.83M Buy
141,595
+137
+0.1% +$4.98K 0.49% 56
2019
Q2 		$5.81M Sell
141,458
-1,453
-1% -$57.7K 0.6% 46
2019
Q1 		$5.73M Buy
142,911
+15,809
+12% +$633K 0.59% 48
2018
Q4 		$5.26M Sell
127,102
-915
-0.7% -$38K 0.93% 33
2018
Q3 		$5.35M Sell
128,017
-119
-0.1% -$4.58K 0.83% 42
2018
Q2 		$4.41M Buy
128,136
+248
+0.2% +$8.47K 0.75% 42
2018
Q1 		$4.31M Buy
127,888
+825
+0.6% +$28.4K 0.74% 40
2017
Q4 		$4.37M Sell
127,063
-977
-0.8% -$33.3K 0.75% 40
2017
Q3 		$4.34M Sell
128,040
-2,152
-2% -$69.2K 0.78% 40
2017
Q2 		$4.15M Buy
130,192
+8,627
+7% +$272K 0.75% 44
2017
Q1 		$3.95M Buy
121,565
+5,107
+4% +$161K 0.71% 45
2016
Q4 		$3.59M Buy
116,458
+2,718
+2% +$83K 0.67% 47
2016
Q3 		$3.65M Buy
113,740
+6,332
+6% +$212K 0.7% 46
2016
Q2 		$3.59M Buy
107,408
+238
+0.2% +$7.6K 0.7% 47
2016
Q1 		$3.01M Buy
107,170
+3,940
+4% +$113K 0.6% 54
2015
Q4 		$3.16M Buy
103,230
+112
+0.1% +$3.52K 0.65% 50
2015
Q3 		$3.12M Buy
103,118
+534
+0.5% +$17.1K 0.68% 52
2015
Q2 		$3.33M Sell
102,584
-97
-0.1% -$3.16K 0.67% 50
2015
Q1 		$3.39M Buy
102,681
+1,654
+2% +$52.6K 0.66% 50
2014
Q4 		$2.99M Buy
101,027
+3,410
+3% +$97.8K 0.59% 52
2014
Q3 		$2.74M Buy
97,617
+3,050
+3% +$85.6K 0.57% 57
2014
Q2 		$2.7M Buy
94,567
+4,639
+5% +$132K 0.56% 57
2014
Q1 		$2.74M Buy
89,928
+2,904
+3% +$86.6K 0.6% 56
2013
Q4 		$2.53M Buy
87,024
+580
+0.7% +$16.9K 0.57% 56
2013
Q3 		$2.36M Buy
86,444
+3,175
+4% +$86.4K 0.58% 54
2013
Q2 		$2.21M Buy
+83,269
New +$2.3M 0.58% 54

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Osborn Williams & Donohoe's PFE Position: Q1 2020 in Review

Osborn Williams & Donohoe reduced its Pfizer (PFE) stake by 6.8% in Q1 2020, selling an estimated $319K and leaving 128,624 shares worth $3.98M. The position accounts for 0.52% of the portfolio, ranked #56.

Osborn Williams & Donohoe first reported a position in PFE in Q2 2013 and has held it in 28 quarters since. The position peaked at $5.81M in Q2 2019. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Osborn Williams & Donohoe held 128,624 shares of Pfizer worth $3.98M as of Q1 2020.
  • Osborn Williams & Donohoe sold 9,367 Pfizer shares in Q1 2020, an estimated $319K.
  • Pfizer made up 0.52% of Osborn Williams & Donohoe's portfolio in Q1 2020, its #56 holding.
  • Osborn Williams & Donohoe first reported a position in Pfizer in Q2 2013 and has held it in 28 quarters since.
  • Osborn Williams & Donohoe's Pfizer position peaked at $5.81M in Q2 2019.
  • 2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Osborn Williams & Donohoe's 13F filing for Q1 2020, filed 4 May 2020.